Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries

OBJECTIVES: Identify molecular mechanisms responsible for the in vitro non-susceptibility to ceftolozane/tazobactam (TOL) in a group of 158 clinical isolates of Pseudomonas aeruginosa from five Latin American countries collected before the introduction of TOL into the clinical practice. METHODS: Cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojica, María F., De La Cadena, Elsa, Ríos, Rafael, García-Betancur, Juan Carlos, Díaz, Lorena, Reyes, Jinnethe, Hernández-Gómez, Cristhian, Radice, Marcela, Gales, Ana C., Castañeda Méndez, Paulo, Munita, José M., Pallares, Christian José, Martínez, José R. W., Villegas, María Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638110/
https://www.ncbi.nlm.nih.gov/pubmed/36353456
http://dx.doi.org/10.3389/fmicb.2022.1035609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638110/
https://www.ncbi.nlm.nih.gov/pubmed/36353456
http://dx.doi.org/10.3389/fmicb.2022.1035609

Ejemplares similares